إعلان شركة الشرق الأوسط للرعاية الصحية (السعودي الألماني الصحية) عن تعيين عضو لجنة المراجعة

Middle East Healthcare Company (Saudi German Health) Announces the Appointment of an Audit Committee Member 4009 SAUDI GERMAN HEALTH 0.15 % 1448/02/15     29/07/2026 16:27:40 Introduction Middle East Healthcare Company (Saudi German Health) announces that its Board of Directors pursuant to a resolution passed by circulation on 14/02/1448H corresponding to 28/07/2026G, approved the appointment of Mr. Yousef Abdulrahman Mohammed Al-Zamea (Non-Board Member) as a member of the Audit Committee, effective from 29/07/2026G until 07/07/2030G, in alignment with the current Board term. Appointed Member Name Mr. Yousef Abdulrahman Mohammed Al Zamea Membership Start Date 2026-07-29 Corresponding to 1448-02-15 Brief Resume of the Appointed Member Mr. Yousef Alzamea has more than 20 years of experience in risk management, compliance, governance regulatory oversight and supervision of financial institutions. He currently serves as Chief Risk Compliance and Cybersecurity Officer at Tawrid for Financing Solutions. He previously held several leadership positions at the Capital Market Authority in listed-company governance disclosure inspection supervision of financial institutions and FinTech regulation. He also worked at Al Rajhi Bank in credit auditing. He holds a Master of Science in Investment from the University of Birmingham and a bachelor’s degree in economics and business administration with a specialization in Accounting from Qassim University. He also holds several professional certifications in investment compliance, governance and risk management. The date of the approval by other official authorities N/A Date of Board Meeting in which Appointed New Member(s) were Appointed 2026-07-28 Corresponding to 1448-02-14 The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. Share